Australian biotech firm CSL says CEO Paul McKenzie to retire
Reuters
Yesterday
Australian biotech firm CSL says CEO Paul McKenzie to retire
Feb 10 (Reuters) - Australia's CSL CSL.AX said on Tuesday its chief executive officer and managing director Paul McKenzie will retire effective February 11.
The firm named Gordon Naylor as the interim CEO and MD.
(Reporting by Rajasik Mukherjee)
((Rajasik.Mukherjee@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.